Skip to content

Different frequency of transcutaneous electrical nerve stimulation in migraine prophylactic treatment

Different frequency of transcutaneous electrical nerve stimulation versus topiramate in migraine prophylactic treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-16008130
Enrollment
Unknown
Registered
2016-03-22
Start date
2016-03-31
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine

Interventions

A:TENS 2Hz
B:TENS100Hz
C:TENS 2Hz/100Hz
D:topiramate

Sponsors

Department of Neurology, Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) an age of 18 to 65 years, migraine according to the International Classification of Headache Disorders, third edition(beta) (ICHD-3 beta) criteria; (2) courses at least 1 year and at least four migraine attacks in the month prior to randomization; (3) Visual Analogue Score>=5; (4) recevied education, can cooperate well in treatment and follow-up periods.

Exclusion criteria

Exclusion criteria: (1) an age out of 18 to 65 years; (2) received regular preventive treatment in last 3 months or received similar non-pharmacological treatment in last year; (3) Have medical history of pacemaker, epilepsy, severe dysfunction of liver or kidney; (4) Severe anxiety or depression, patients with broken skin or paraesthesia.

Design outcomes

Primary

MeasureTime frame
50% response;Visual Analogue Score;monthly headache days;headache duration;monthly medicine taken;

Secondary

MeasureTime frame
degree of anxiety;degree of depression;influence of headache;

Countries

China

Contacts

Public ContactShengyuan Yu

Chinese PLA General Hospital

ysy1963@126.com+86 010-55499118

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026